We compared demographic, clinical characteristics, and icatibant‐treatment outcomes of French patients with HAE with C1 INH deficiency or dysfunction (types I and II) and those with HAE‐nC1 INH. The gene discussed is COL18A1; the disease is hyperinsulinemic hypoglycemia, familial, 4.